Mandarin Oriental International Ltd
F:1C4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mandarin Oriental International Ltd
F:1C4
|
HK |
|
A
|
Atara Biotherapeutics Inc
F:AT2
|
US |
|
S
|
Sabina Gold & Silver Corp
F:RXC
|
CA |
|
T
|
TopBuild Corp
BMV:BLD
|
US |
|
F
|
Federated Hermes Inc
F:3KC
|
US |
|
Ironbark Zinc Ltd
ASX:SKM
|
AU |
|
L
|
Linde PLC
XMUN:LIN
|
UK |
|
ASR Nederland NV
F:A16
|
NL |
|
L
|
Lenzing AG
VSE:LNZ
|
AT |
|
Nitori Holdings Co Ltd
OTC:NCLTF
|
JP |
|
Taisei Corp
TSE:1801
|
JP |
|
E
|
Eaton Corporation PLC
XMUN:3EC
|
IE |
|
Tikehau Capital SCA
PAR:TKO
|
FR |
|
D
|
Deere & Co
DUS:DCO
|
US |
|
Groupon Inc
NASDAQ:GRPN
|
US |
|
SKF AB
F:SKFB
|
SE |
|
Vertiv Holdings Co
NYSE:VRT
|
US |
|
B
|
BlackBerry Ltd
XBER:RI1
|
CA |
|
Virgin Galactic Holdings Inc
F:0QL0
|
US |
|
S
|
Star Diamond Corp
SWB:GOC
|
CA |
Wall St Price Targets
1C4 Price Targets Summary
Mandarin Oriental International Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1C4's stock price target?
Not Available
1C4 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Mandarin Oriental International Ltd?
Projected CAGR
-7%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 1 year is -7%.
What is the Operating Income forecast for Mandarin Oriental International Ltd?
Projected CAGR
-76%
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 1 year is -76%.